As shown in Figures 5C, E, the m6Arisk score was positively correlated with a majority of the immunotherapy predicted-related pathways, including IFN-Gamma signature, base-excision repair, cell cycle, Fanconi anemia pathway, p53 signaling pathway, MicroRNAs in cancer, proteasome, and pyrimidine metabolism. This evidence concerns the gene TP53 and cancer.